Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

New champions crowned at first-year athletics
2017-02-03

Description:UFS first-year athletics  Tags: UFS first-year athletics  longdesc=

It was a day filled with excitement on and off the
track when the residences at the University of
the Free State competed against each other
during the first-year athletics event.
Photo: Charl Devenish

The University of the Free State’s first-year athletics is an institution. It is a day marked by colour, spirit, and hoarse voices, but in 2017 produced something different than the last couple of years.

For the first time in four years, new athletics champions were crowned in both the men’s and women’s sections when Veritas and Sonnedou walked away with the trophies at Pellies Park on the Bloemfontein Campus on 25 January 2017.

Wag-’n-Bietjie, Vishuis relinquish titles

Sonnedou, who came second in 2016, broke Wag-’n-Bietjie’s stronghold of the past six years by winning the women’s athletics trophy. Furthermore, Sonnedou won this trophy more than a decade ago – in 2004. Veritas, who won the men’s athletics trophy for the first time since 2011, also put a stop to Vishuis’s dominance. House Abraham Fischer has worn the athletics crown for the past three years.

This year, Vishuis (70 points) took second place after Veritas (76), with Armentum (61) third. Sonnedou (99 points) easily triumphed in the women’s division, while Akasia (36) and Wag-?-Bietjie (34) respectively took second and third place.

Veritas captures overall Spirit trophy

However, the event is about much more than the action on and around the athletics track. First-years also get the opportunity to show pride in their residences by shouting at the top of their lungs.

Veritas, better-known in recent years for its excellent sêr groups, asserted itself even more by being named as the overall winner of the Spirit trophy. This residence was also the winner of the men’s section. Harmony won the Spirit trophy for women’s residences, while Conlaurês was the co-ed residence with the greatest spirit.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept